Compare TNYA & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNYA | FINW |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.5M | 194.4M |
| IPO Year | 2021 | 2021 |
| Metric | TNYA | FINW |
|---|---|---|
| Price | $0.80 | $13.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 41.3K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.96 | 21.51 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $160.48 |
| Revenue Next Year | N/A | $35.27 |
| P/E Ratio | ★ N/A | $70.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $12.82 |
| 52 Week High | $2.35 | $22.49 |
| Indicator | TNYA | FINW |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 43.52 |
| Support Level | $0.65 | $13.72 |
| Resistance Level | $0.80 | $15.17 |
| Average True Range (ATR) | 0.07 | 0.58 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 39.32 | 3.80 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.